Newsroom

Sorted by: Latest

-

Innate Pharma Announces Conference Call and Webcast for Q1 2026 Business Update

MARSEILLE, France--(BUSINESS WIRE)--Innate Pharma announces conference call and webcast for Q1 2026 Business Update...
-

Innate Pharma organise une conférence téléphonique et un webcast pour présenter ses résultats du premier trimestre 2026

MARSEILLE--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd'hui qu'elle organisera une conférence téléphonique le mercredi 13 mai 2026 à 13H30 CEST / 7H30 EDT afin de présenter ses résultats financiers et l’avancée de son portefeuille pour le premier trimestre 2026. La conférence sera animée par : Jonathan Dickinson, Directeur Général Sonia Quaratino, Vice-présidente exécutive, Directrice Médicale Yannis Mor...
-

ARKEMA: FIRST-QUARTER 2026 RESULTS

PARIS--(BUSINESS WIRE)--Regulatory News: Arkema (PARIS:AKE): Stable volumes supported by a stronger March and superior growth in key attractive markets while adapting swiftly to the Middle East context Stable Group volumes versus last year, supported by growth across all Specialty Materials segments and an improvement in March after a slow start to the year Contrasting dynamics by region, with ongoing growth in Asia in Specialty Materials while overall demand in Europe and in the US remained so...
-

ARKEMA : RÉSULTATS DU 1ER TRIMESTRE 2026

PARIS--(BUSINESS WIRE)--Regulatory News: Arkema (PARIS:AKE): Volumes stables soutenus par un mois de mars plus solide et une croissance supérieure dans des marchés clés attractifs, tout en s’adaptant rapidement au contexte au Moyen-Orient Volumes du Groupe stables par rapport à l’an dernier, soutenus par une croissance dans l’ensemble des segments de Matériaux de Spécialités et par une amélioration en mars après un démarrage lent de l’année Dynamiques contrastées selon les régions, avec une cro...
-

Antin Infrastructure Partners SA: Investment Momentum Continues; Launch of Mid Cap II Fundraising

PARIS & LONDON & NEW YORK--(BUSINESS WIRE)--Regulatory News: Antin Infrastructure Partners SA (Paris:ANTIN): AUM €33.8bn +1.7% over the LTM Fee-Paying AUM €22.1bn +3.0% over the LTM HIGHLIGHTS Continued momentum in capital deployment, with three new investments signed in 1Q 2026 across Flagship, Mid Cap and NextGen Fundraising for Mid Cap II is progressing well, with strong engagement and positive feedback from both existing and new investors; activation is expected in 2Q 2026 Fee-Paying AUM ro...
-

Workato Launches Otto, the Trusted AI Teammate that Gets Work Done

PALO ALTO, Calif.--(BUSINESS WIRE)--Workato, the leader in Enterprise Model Context Protocol (MCP) and orchestration, today announced Otto by Workato, a trusted AI teammate that executes work across systems, coordinates teams, and completes complex business processes with control built in. Otto is a digital teammate that moves from intent to action, working across every system your business runs on, with approvals, auditability, and governance from day one. Powered by Workato Enterprise MCP, th...
-

Ingram Micro Holding Corporation Announces Pricing of Secondary Offering of Common Stock by its Principal Stockholder.

IRVINE, Calif.--(BUSINESS WIRE)--Ingram Micro Holding Corporation (the “Company”) announced today the pricing of the previously announced secondary public offering by Ingram Holdco, LLC, an affiliate of Platinum Equity, LLC (the “Selling Stockholder”), of 12,740,384 shares of the Company’s common stock (“Common Stock,” and such offering, the “Offering”), at a price to the public of $26.00 per share, pursuant to an automatic shelf registration statement filed with the Securities and Exchange Com...
-

Hisense Delivers 38% Sales Uplift in Western Europe Markets With NIQ’s AI-Powered Market Intelligence

CHICAGO--(BUSINESS WIRE)--Hisense has accelerated international expansion using NIQ's AI-powered intelligence, improving local market decision-making and growth....
-

Takeda presenta resultados positivos preliminares del ensayo pivotal de fase 2/3 de TAK-881 en inmunodeficiencia primaria (IDP)

OSAKA, Japón y CAMBRIDGE, Massachusetts--(BUSINESS WIRE)--Takeda (TSE: 4502 / NYSE: TAK) presentó hoy resultados preliminares del estudio TAK-881-3001, un ensayo clínico pivotal de fase 2/3 en pacientes con inmunodeficiencia primaria (IDP), que cumplió su criterio principal de evaluación al demostrar comparabilidad farmacocinética (PK) entre TAK-881 en investigación [inmunoglobulina subcutánea humana al 20 % (SCIG 20 %) con hialuronidasa humana recombinante] y HYQVIA [inmunoglobulina humana al...
-

Resumen: Wolters Kluwer mejora el área de trabajo de IA jurídica Libra con funciones mejoradas de revisión de contratos y flujos de trabajo integrados

ALPHEN AAN DEN RIJN, Países Bajos--(BUSINESS WIRE)--Asuntos jurídicos y normativos de Wolters Kluwer ha anunciado hoy el lanzamiento de una nueva versión de Libra by Wolters Kluwer, su área de trabajo jurídico con tecnología de IA que integra importantes funciones de flujo de trabajo con contenido fiable elaborado por expertos. La actualización introduce avances significativos en la revisión de contratos, la integración de flujos de trabajo y la facilidad de uso, y refuerza el papel de Libra co...